News View Non-AMP

Coinbase CEO Brian Armstrong Bags $130M for Longevity Startup NewLimit

Published by
Andrea

While most crypto CEOs are busy navigating market volatility,Brian Armstrong is playing a far bigger game – taking on human aging and Washington regulations at the same time. Not exactly your typical founder story, right? 

One moment he’s rallying for stablecoin legislation on Capitol Hill, the next he’s funding research to literally reverse the aging process.

Here’s the latest on Armstrong, for all Coinbase enthusiasts out there! 

NewLimit Raises $130M to Rewire Human Longevity

Armstrong’s biotech venture NewLimit, co-founded with former GV partner Blake Byers and stem cell scientist Jacob Kimmel, just closed a $130 million Series B round. The startup, now valued at $810 million, is developing therapies that aim to restore youthful function to aging cells through epigenetic reprogramming.

Early results are promising. The team has identified three prototype medicines targeting liver cells – improving their fat and alcohol processing capabilities in lab tests. 

While human trials are still years away, NewLimit is expanding into immune system research, with Armstrong citing the urgency of fighting what he calls the “largest source of human tragedy” – aging.

The round was led by Kleiner Perkins and backed by a powerful lineup of investors including Founders Fund, Elad Gil, Patrick Collison, and Garry Tan.

Say No to Aging: Tech Titans Are All In!

Armstrong isn’t alone in this mission. He joins the ranks of tech elites like Jeff Bezos, Larry Ellison, and Vitalik Buterin – all pouring hundreds of millions into anti-aging research. But Armstrong’s approach is distinctive: part-scientist, part-operator, and always ten steps ahead.

Fighting for Stablecoin Regulations

The Coinbase CEO hasn’t loosened his grip on crypto advocacy. Just yesterday on X, he called on the U.S. Senate to move forward on the GENIUS Act – a stablecoin regulation bill that could finally bring clear rules to the space.

The GENIUS Act would introduce a federal licensing regime, enforce reserve requirements for issuers, and create a dual regulatory model – splitting oversight between federal and state levels depending on issuer size. 

The push comes just as the Treasury predicts stablecoins could surge from $230B to $2T by 2028, presenting both an opportunity and a risk to traditional banking systems.

Here’s how we see it: Brian Armstrong is betting on the future, and he’s doing it from all sides.

FAQs

What is Brian Armstrong’s biotech company NewLimit?

NewLimit is a biotech startup co-founded by Brian Armstrong to reverse aging via epigenetic cell reprogramming.

What does the GENIUS Act mean for stablecoin regulation?

The GENIUS Act proposes federal and state oversight, reserve rules, and licenses to regulate stablecoin issuers.

Andrea

Recent Posts

Robinhood Plans to Build Blockchain Tokenization Platform to Enable EU Investors to Access U.S. Stocks

Robinhood’s Q1 earnings report showed that the company is heavily reliant on crypto trading, despite…

May 8, 2025

OCC Approves Banks to Handle Crypto Assets: Key Takeaways and Market Impact

The U.S. OCC has aligned with other agencies to issue clear crypto regulations under the…

May 8, 2025

Bitcoin Dominance Nears 71% –  Is It a Warning or the Calm Before Altcoin Season?

Bitcoin is once again dominating the crypto conversation, not just in price, but in overall…

May 8, 2025

Altseason Watch: Will Altcoins Rally in 2025 After Fed Chair Announced Further Quantitative Tightening (QT)

Rising Bitcoin dominance has continued to reign havoc across the altcoin market amid global trade…

May 8, 2025

XRP Investors Rush To Xpfinance, Ripple’s First Non-Custodial Lending Platform Set To Launch XPF Token

Despite recent market turbulence pulling XRP prices below $2.2, Ripple's ecosystem continues to defy bearish…

May 8, 2025

U.S. Fed Leaves Lending Rate Unchanged Amid Executive Pressure: What Next for Bitcoin Price?

Wall Street experts anticipate the Fed to cut its rate later this year to stimulate…

May 8, 2025